Drizzle Health files Form D for SAFE offering, discloses $600,000 raised
The Baltimore-based biotechnology company reported one investor and a sale date of September 2, 2026, in a notice filed with the SEC.
Drizzle Health, LLC, a Delaware limited liability company based in Baltimore, Maryland, filed a Form D notice with the Securities and Exchange Commission disclosing an exempt securities offering. The company is organized as a limited liability company incorporated more than five years ago in Delaware.1
The securities being offered are simple agreements for future equity, known as SAFEs.1 The offering relies on the Rule 506(b) exemption.1 The filing lists a date of first sale of September 2, 2026.1
The total amount sold was reported as $600,000, with the total offering amount and remaining amount to be sold both listed as indefinite.1 The company reported a total of one investor who has already invested in the offering.1 The minimum investment accepted from any outside investor was listed as $0.1
No sales commissions or finders' fees were reported, both listed at $0.1 The amount of proceeds used for payments to executive officers, directors or promoters was also listed as $0.1
The filing names Digvijay Singh and Bonolo Mathekga as executive officers, directors, and promoters, and Yukari Manabe as a director.1 All three list the same Baltimore address as the company. The filing identifies the issuer's industry as biotechnology within the health care sector.1
The company stated it does not intend the offering to last more than one year.1 The notice was signed by Digvijay Singh as President on November 10, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.